Literature DB >> 28724278

Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma.

Mirhojjat Khorasanizadeh1, Mahsa Eskian1, Nima Rezaei2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28724278

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN： 0044-6025


× No keyword cloud information.
  3 in total

Review 1.  Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis.

Authors:  Mahsa Eskian; MirHojjat Khorasanizadeh; Amal H Assa'ad; Nima Rezaei
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

2.  Does benralizumab effectively treat chronic obstructive pulmonary disease? A protocol of systematic review and meta-analysis.

Authors:  Ru Chen; Ke-Xin Wang; Xue Meng; Wen Zhou
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

3.  Translational Analysis of Moderate to Severe Asthma GWAS Signals Into Candidate Causal Genes and Their Functional, Tissue-Dependent and Disease-Related Associations.

Authors:  Michael A Portelli; Kamini Rakkar; Sile Hu; Yike Guo; Ian M Adcock; Ian Sayers
Journal:  Front Allergy       Date:  2021-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.